The home health and hospice landscape continues to shift with major M&A activity. Case in point: Humana Inc. has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice to sell the firm a majority interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home subsidiary for about $2.8 billion in cash, the Louisville, Kentucky-based behemoth says in a release. “Humana had previously indicated its intent to divest a majority stake in these non-core businesses when it acquired the remaining interest in Kindred at Home in April 2021,” the company notes. “While palliative and hospice services are important components in the continuum of care that Humana offers patients, we are confident that we can deliver desired patient outcomes and improved customer experiences through partnership models rather than fully owning KAH Hospice,” Humana CFO Susan Diamond says in the release. Humana intends to use proceeds from the transaction for the repayment of debt and share repurchases, it says.